Viewing Study NCT01854294


Ignite Creation Date: 2025-12-25 @ 1:33 AM
Ignite Modification Date: 2026-02-06 @ 6:52 PM
Study NCT ID: NCT01854294
Status: COMPLETED
Last Update Posted: 2021-04-27
First Post: 2013-05-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)
Sponsor: Genervon Biopharmaceuticals, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module